CHA News Article

HRSA Posts Results of 340B Audits

The Health Resources and Services Administration (HRSA) has announced the results of 51 audits it conducted of 340B drug pricing program participants. Begun in 2012, the audits included 410 covered entity sites. According to HRSA, results range from no adverse findings to minor and more significant infractions. All of the current audit findings are available on HRSA’s website.

HRSA also plans to formalize existing program guidance in a proposed rule by June of this year, addressing the definition of an eligible patient, compliance requirements for contract pharmacy arrangements, hospital eligibility criteria and eligibility of off-site facilities. For more information about the 340B program, visit